Effect of Biomaterial Electrical Charge on Bone Morphogenetic Protein-2-Induced In Vivo Bone Formation

被引:1
|
作者
Olthof, Maurits G. L. [1 ,2 ,3 ,4 ]
Kempen, Diederik H. R. [5 ]
Liu, Xifeng [1 ,2 ]
Dadsetan, Mahrokh [1 ,2 ]
Tryfonidou, Marianna A. [3 ]
Yaszemski, Michael J. [1 ,2 ]
Dhert, Wouter J. A. [3 ,4 ]
Lu, Lichun [1 ,2 ]
机构
[1] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, 200 First St SW,MS 3-69, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA
[3] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands
[4] Univ Med Ctr, Dept Orthopaed, Utrecht, Netherlands
[5] OLVG, Dept Orthopaed Surg, Amsterdam, Netherlands
关键词
electrical charge; bone morphogenetic protein-2 release; biomaterials; bone tissue engineering; oligo[(polyethylene glycol) fumarate; poly(lactic-co-glycolic acid); CONTROLLED-RELEASE; CALCIUM-PHOSPHATE; SUSTAINED DELIVERY; CALLUS FORMATION; BMP-2; DELIVERY; GROWTH-FACTORS; CELL-ADHESION; TISSUE; HYDROXYAPATITE; DIFFERENTIATION;
D O I
10.1089/ten.tea.2018.0140
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Biomaterials that act as both protein delivery vehicle and scaffold can improve the safety and efficacy of bone morphogenetic protein-2 (BMP-2) for clinical applications. However, the optimal scaffold characteristics are not known. The osteoinductive and osteoconductive capacity of a fixed electrically charged surface is thus far unexplored. Therefore, in this study, we aim to investigate the effect of different electrical states on BMP-2-induced bone formation in oligo[(polyethylene glycol) fumarate] (OPF) hydrogels. Neutral, negatively, or positively charged scaffolds were fabricated using unmodified OPF (neutral charge), sodium methacrylate crosslinked OPF (negative charge), or [2-(methacryloyloxy) ethyl] trimethylammonium chloride crosslinked OPF (positive charge), respectively. To allow investigation of surface charge for different BMP-2 release rates, three BMP-2 release profiles were generated by protein encapsulation into poly(lactic-co-glycolic acid) microspheres and/or adsorption on the OPF composite. Release of radiolabeled I-125-BMP-2 was analyzed in vitro and in vivo and bone formation was assessed after 9 weeks of subcutaneous implantation in rats. Negatively charged OPF generated significantly more bone formation compared with neutral and positively charged OPF. This effect was seen for all three loading methods and subsequent BMP-2 release profiles. Along with charge modifications, a more sustained release of BMP-2 improved overall bone formation in OPF composites. Overall, this study clearly shows that negative charge enhances bone formation compared with neutral and positive charge in OPF composites. Impact Statement Biomaterials can play a dual role in bone regeneration: they enable local sustained delivery of growth factors, such as bone morphogenetic protein-2 (BMP-2), while they provide structural support as scaffold. By better imitating the properties of native bone tissue, scaffolds may be both osteoconductive and osteoinductive. The latter can be achieved by modifying the electrical charge of the surface. The present work uses tunable oligo[(polyethylene glycol) fumarate] hydrogel and demonstrates that negative charge enhances BMP-2-induced bone formation compared with neutral or positive charge. Altogether, this indicates that tissue-specific surface charge modifications of biomaterials hold great promise in the field of tissue regeneration.
引用
收藏
页码:1037 / 1052
页数:16
相关论文
共 50 条
  • [11] Bone morphogenetic protein-2-induced transformation - Involves the activation of mammalian target of rapamycin
    Langenfeld, EM
    Kong, YX
    Langenfeld, J
    MOLECULAR CANCER RESEARCH, 2005, 3 (12) : 679 - 684
  • [12] Ectopic bone formation induced by bone morphogenetic protein
    Shin, HI
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (05) : 1186 - 1186
  • [13] Enhanced Bone Morphogenetic Protein-2-Induced Ectopic and Orthotopic Bone Formation by Intermittent Parathyroid Hormone (1-34) Administration
    Kempen, Diederik H. R.
    Lu, Lichun
    Hefferan, Theresa E.
    Creemers, Laura B.
    Heijink, Andras
    Maran, Avudaiappan
    Dhert, Wouter J. A.
    Yaszemski, Michael J.
    TISSUE ENGINEERING PART A, 2010, 16 (12) : 3769 - 3777
  • [14] In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector
    Alden, TD
    Pittman, DD
    Hankins, GR
    Beres, EJ
    Engh, JA
    Das, S
    Hudson, SB
    Kerns, KM
    Kallmes, DF
    Helm, GA
    HUMAN GENE THERAPY, 1999, 10 (13) : 2245 - 2253
  • [15] Influence of Residual Bone on Recombinant Human Bone Morphogenetic Protein-2-Induced Periodontal Regeneration in Experimental Periodontitis in Dogs
    Saito, Akira
    Saito, Emiko
    Handa, Ryohei
    Honma, Yoshiyuki
    Kawanami, Masamitsu
    JOURNAL OF PERIODONTOLOGY, 2009, 80 (06) : 961 - 968
  • [16] The effect of root surface demineralization on bone morphogenetic protein-2-induced healing of rat periodontal fenestration defects
    King, GN
    King, N
    Hughes, FJ
    JOURNAL OF PERIODONTOLOGY, 1998, 69 (05) : 561 - 570
  • [17] Recombinant Human Bone Morphogenetic Protein-2-Induced Craniosynostosis and Growth Restriction in the Immature Skeleton
    Kinsella, Christopher R., Jr.
    Cray, James J.
    Durham, Emily L.
    Burrows, Anne M.
    Vecchione, Lisa
    Smith, Darren M.
    Mooney, Mark P.
    Cooper, Gregory M.
    Losee, Joseph E.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 127 (03) : 1173 - 1181
  • [18] A synthetic compound that potentiates bone morphogenetic protein-2-induced transdifferentiation of myoblasts into the osteoblastic phenotype
    Kato, Satoshi
    Sangadala, Sreedhara
    Tomita, Katsuro
    Titus, Louisa
    Boden, Scott D.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 349 (1-2) : 97 - 106
  • [19] A synthetic compound that potentiates bone morphogenetic protein-2-induced transdifferentiation of myoblasts into the osteoblastic phenotype
    Satoshi Kato
    Sreedhara Sangadala
    Katsuro Tomita
    Louisa Titus
    Scott D. Boden
    Molecular and Cellular Biochemistry, 2011, 349 : 97 - 106
  • [20] Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo
    Bradley, J. D.
    Cleverly, D. G.
    Burns, A. M.
    Helm, N. B.
    Schmid, M. J.
    Marx, D. B.
    Cullen, D. M.
    Reinhardt, R. A.
    JOURNAL OF PERIODONTAL RESEARCH, 2007, 42 (03) : 267 - 273